# MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors

> **NCT06912152** · PHASE1 · RECRUITING · sponsor: **Zhejiang University** · enrollment: 12 (estimated)

## Conditions studied

- B7-H3-positive Advanced Malignant Solid Tumors Advanced Primary Peritoneal Tumors or Secondary Abdominal Metastatic Malignant Solid Tumors

## Interventions

- **BIOLOGICAL:** MT027 CAR-T cells

## Key facts

- **NCT ID:** NCT06912152
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-12
- **Primary completion:** 2028-10-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06912152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06912152, "MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT06912152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*